TerrAscend (TSNDF) Current Assets (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Current Assets of $102.4 million for Q1 2026, up 1.23% year-over-year from $101.2 million in Q1 2025, and down 6.96% quarter-over-quarter from $110.1 million in Q4 2025.
TerrAscend (TSNDF) Current Assets (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Current Assets for 6 consecutive years, with $102.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 1.23% year-over-year to $102.4 million; the TTM figure through Mar 2026 stood at $102.4 million (up 1.23% YoY), while the FY2025 annual figure was $110.1 million, down 37.75% from the prior year.
- Current Assets slipped to $102.4 million in Q1 2026 per TSNDF's latest filing, from $110.1 million in the prior quarter.
- Across five years, Current Assets topped out at $187.1 million in Q1 2022 and bottomed at $97.7 million in Q1 2024.
- Historically, Current Assets has averaged $120.1 million across 5 years, with a median of $110.1 million in 2025.
- Annual changes were most pronounced in 2023 — Current Assets sank 39.2% — and 2024, when it soared 71.92%.
- TerrAscend's Current Assets stood at $122.0 million in 2022, then retreated by 15.66% to $102.9 million in 2023, then soared by 71.92% to $176.9 million in 2024, then tumbled by 37.75% to $110.1 million in 2025, then slipped by 6.96% to $102.4 million in 2026.
- Business Quant data shows TSNDF's Current Assets at $102.4 million in Q1 2026, $110.1 million in Q4 2025, and $119.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 3.22 Bn |
| 10 | TerrAscend | 187.35 Mn | 145.23 Mn | 36.25 Mn | 113.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 113.46 Mn |
| Mar 31, 2026 | 102.44 Mn |
| Dec 31, 2025 | 110.11 Mn |
| Sep 30, 2025 | 119.37 Mn |
| Jun 30, 2025 | 133.08 Mn |
| Mar 31, 2025 | 101.20 Mn |
| Dec 31, 2024 | 176.89 Mn |
| Sep 30, 2024 | 105.71 Mn |
| Jun 30, 2024 | 104.81 Mn |
| Mar 31, 2024 | 97.66 Mn |
| Dec 31, 2023 | 102.89 Mn |
| Sep 30, 2023 | 107.21 Mn |
| Jun 30, 2023 | 106.63 Mn |
| Mar 31, 2023 | 113.78 Mn |
| Dec 31, 2022 | 121.99 Mn |
| Sep 30, 2022 | 113.40 Mn |
| Jun 30, 2022 | 137.32 Mn |
| Mar 31, 2022 | 187.14 Mn |
| Dec 31, 2021 | 172.49 Mn |